Diagnostic Differences Between Nephrogenic and Central Diabetes Insipidus

Pathophysiological Characteristics

Patients with central diabetes insipidus (CDI) have low or absent plasma ADH levels due to deficient production, as stated by the American College of Nephrology 1, 2
Nephrogenic diabetes insipidus (NDI) is characterized by insensitivity of the distal nephron to ADH despite normal or elevated plasma ADH levels, according to the National Institute of Diabetes and Digestive and Kidney Diseases 1, 3, 4
Plasma copeptin levels above a certain threshold are diagnostic for NDI in adult patients, indicating significantly elevated ADH levels, as recommended by the European Society of Endocrinology 1, 4

Both NDI and CDI present with decreased urine osmolality, increased plasma osmolality, and increased urine flow rate, as reported by the American Society of Nephrology 1, 3
The critical difference is plasma ADH levels: in NDI, normal or elevated plasma ADH levels are present, while in CDI, low or absent plasma ADH levels are observed, as noted by the Endocrine Society 2, 3

Response to desmopressin administration is a key diagnostic test: CDI patients show a positive response, while NDI patients show minimal or no response, as stated by the American Academy of Pediatrics 1, 2
CDI is treated with desmopressin to replace the deficient hormone, while NDI requires different management strategies, including thiazide diuretics and ensuring adequate fluid intake, as recommended by the National Kidney Foundation 2, 3

The European Society of Endocrinology recommends that nephrogenic DI be treated with thiazide diuretics, low-salt diet, and ad libitum fluid access, as desmopressin is ineffective 5
In emergency management of nephrogenic DI, the American Academy of Pediatrics suggests avoiding NaCl 0.9% solutions and using 5% dextrose instead due to the risk of severe hypernatremia 5